EPISODE · Aug 1, 2025 · 16 MIN
Aida Perramon-Malavez and Antoni Soriano-Arandes on the real-world impact of nirsevimab
from The Lancet Regional Health Europe in conversation with · host The Lancet Group
Can nirsevimab transform prevention strategies for respiratory infection in infants? Join Stephanie Becker as she sits down with Aida Perramon-Malavez and Antoni Soriano-Arandes to explore the significant threat that respiratory syncytial virus (RSV) poses to young children. Discover insights into the real-world impact of nirsevimab implementation during its first season, explore how prevention strategies vary across Europe, and hear about the urgent need for equitable access to vaccination worldwide. Read the full article: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00126-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanepe
Embed this episode
What this episode covers
Can nirsevimab transform prevention strategies for respiratory infection in infants? Join Stephanie Becker as she sits down with Aida Perramon-Malavez and Antoni Soriano-Arandes to explore the significant threat that respiratory syncytial virus (RSV) poses to young children. Discover insights into the real-world impact of nirsevimab implementation during its first season, explore how prevention strategies vary across Europe, and hear about the urgent need for equitable access to vaccina...
Ready to play
Aida Perramon-Malavez and Antoni Soriano-Arandes on the real-world impact of nirsevimab
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.